Subacute and Chronic Myelomonocytic Leukemia

  • R. Zittoun
Part of the Haematology and Blood Transfusion / Hämatologie und Bluttransfusion book series (HAEMATOLOGY, volume 27)

Abstract

Subacute and chronic myelomonocytic leukemia have been previously described under different names. Recent works have underlined the most common features of these syndromes [3, 8, 10, 16, 28, 29]. Since numerous other papers refer to them, giving additional etiological and biological data, this talk will focus on certain specific topics. I shall try to clarify the problem of evolution and prognosis, to discuss treatment, and to point out what we have learned from this type of leukemia.

Keywords

Leukemia Anemia Melphalan Lysozyme Hydrolase 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bennet JM, Catovski D, Daniel MT, Flandrin G, Galton DAS, Gralnick H, Sultan C (1976) Proposals for the classification of the acute leukaemias. French American British (FAB) co-operative group. Br J Haematol 33: 451–458CrossRefGoogle Scholar
  2. 2.
    Briere J, Dresch C, Briere JF, Faille A (1977) Leucémies myelomonocytaires subaigues ou chroniques de l’adulte. Etude clinique et données cinétiques. A propos de 46 observations. Actual Hematol (Paris) 53–80Google Scholar
  3. 3.
    Broxmeyer HE, Grossbard E, Jacobsen N, Moore MAS (1978) Evidence for a proliferative advantage of human leukemia colony-forming cells in vitro. J Natl Cancer Inst 60: 513PubMedGoogle Scholar
  4. 4.
    Cohen JR, Creger WP, Greenberg PL, Schrier SL (1979) Subacute myeloid leukemia. A clinical review. Am J Med 66: 959–966PubMedCrossRefGoogle Scholar
  5. 5.
    Dresch C, Faille A, Poirier O, Balitrand N, Najean Y (1979) Bone marrow cell kinetics and culture in chronic and subacute myelomonocytic leukemia. Physiopathological interpretation and prognostic importance. Leuk Res 4: 129–142CrossRefGoogle Scholar
  6. 6.
    Dreyfus B, Rochant M, Sultan C (1969) Anémies réfractaires: enzymopathies acquises des cellules souches hématopoiétiques. Nouv Rev Fr Hematol 9: 65–86PubMedGoogle Scholar
  7. 7.
    Fialkow PJ, Jacobson RJ, Papayannopoulou T (1977) Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet, and monocyte-macrophage. Am J Med 63: 125–130PubMedCrossRefGoogle Scholar
  8. 8.
    Geary CG, Catovsky D, Wiltshaw E, Milner GR, Scholes MC, van Noorden S, Wadsworth LD, Muldal S, Maclver JE, Galton DAG (1975) Chronik myelomonocytic leukaemia. Br J Haematol 30: 289–302PubMedCrossRefGoogle Scholar
  9. 9.
    Hansen NE (1974) Plasma lysozyme. A measure of neutrophil turnover. An analytical review. Ser Haematol 7: 1–87PubMedGoogle Scholar
  10. 10.
    Hurdle ADF, Garson OM, Buist DGP (1972) Clinical and cytogenetic studies in chronic myelomonocytic leukaemia. Br J Haematol 22: 773–782PubMedGoogle Scholar
  11. 11.
    Kyle RA, Pierre RV, Bayrd ED (1970) Multiple myeloma and acute myelomonocytic leukemia. Report of four cases possibly related to Melphalan. N Engl J Med 283: 1121–1125PubMedCrossRefGoogle Scholar
  12. 12.
    Labedzki L, Iiiiger HJ (1979) Erfolgreiche Behandlung der chronischen myelomonozytären Leukämie mit VP 16–213. Blut 38: 421–424PubMedCrossRefGoogle Scholar
  13. 13.
    Maldonado JE, Hanion DG (1965) Monocytosis: a current appraisal. Mayo Clin Proc 40: 248–259PubMedGoogle Scholar
  14. 14.
    Mathe G, Schwarzenberg L, Pouillart P, Oldman R, Weiner R, Jasmin C, Rosenfeld C, Hayat M, Misset JL, Musset M, Schneider M, Amiel JL, de Vassal F (1974) Two epipodophyllotoxin derivatives, VM 26 and VP 16–213 in the treatment of leukemias, hemato-sarcomas and lymphomas. Cancer 34: 985–992PubMedCrossRefGoogle Scholar
  15. 15.
    McKenna RW, Bloomfield CD, Dick F, Nesbit ME, Bönning RD (1975) Acute monoblastic leukemia: diagnosis and treatment of ten cases. Blood 46: 481–494PubMedGoogle Scholar
  16. 16.
    Miescher PA, Farcquet JJ (1974) Chronic myelomonocytic leukemia in adults. Semin Hematol 11: 129–139PubMedGoogle Scholar
  17. 17.
    Milner GR, Testa NG, Geary CG, Dexter TM, Muldai J, Maclver JE, Lajtha LG (1977) Bone marrow culture studies in refractory cytopenia and “Smouldering Leukaemia”. Br J Haematol 35: 251–261PubMedCrossRefGoogle Scholar
  18. 18.
    Rachmilewitz B, Rachmilewitz M, Chaouat M, Schlesinger M (1977) The synthesis of transcobalamin II, a vitamin B 12 transport protein by stimulated mouse peritoneal macrophages. Biomedicine 27: 213–214PubMedGoogle Scholar
  19. 19.
    Saarni MI, Linman JW (1971) Myelomonocytic leukemia: disorderly proliferation of all marrow cells. Cancer 27: 1221–1230PubMedCrossRefGoogle Scholar
  20. 20.
    Sachs L (1978) The differentiation of myeloid leukaemia cells: new possibilities for therapy. Br J Haematol 40: 509–517PubMedCrossRefGoogle Scholar
  21. 21.
    Sexauer J, Kass L, Schnitzer B (1974) Subacute myelomonocytic leukemia. Clinical, morphologic and ultrastructural studies of 10 cases. Am J Med 57: 853–861PubMedCrossRefGoogle Scholar
  22. 22.
    Sultan C, Marquet M, Joffroy Y (1974) Etude de certaines dysmyélopoieses acquises idiopathiques et secondaires par culture de moelle in vitro. Ann Med Interne (Paris) 125: 599–602Google Scholar
  23. 23.
    Third, Fourth and Fifth reports (1950) of the Committee for clarification of the Nomenclature of Cells and Diseases of the Blood and Blood-Forming Organs. Am J Clin Pathol 20: 562–579Google Scholar
  24. 24.
    Tulliez M, Ricard MF, Jan F, Sultan C (1974) Preleukaemic abnormal myelopoiesis induced by chlorambucil: a case study. Scand J Haematol 13: 179–183PubMedCrossRefGoogle Scholar
  25. 25.
    Vismans JJ, Briet E, Meijer K, Ottolander GJ (1980) Azathioprine and subacute myelomonocytic leukemia. Acta Med Scand 207: 315–319PubMedCrossRefGoogle Scholar
  26. 26.
    Zittoun J, Zittoun R, Marquet J, Sultan C (1975) The three transcobalamins in myeloproliferative disorders and acute leukaemia. Br J Haematol 31: 287–298PubMedCrossRefGoogle Scholar
  27. 27.
    Zittoun J, Marquet J, Zittoun R (1975) The intracellular content of the three transcobalamins at various stages of normal and leukaemic myeloid cell development. Br J Haematol 31: 299–310PubMedCrossRefGoogle Scholar
  28. 28.
    Zittoun R (1976) Subacute and chronic myelomonocytic leukaemia: a distinct hamatological entity. Br J Haematol 32: 1–7PubMedCrossRefGoogle Scholar
  29. 29.
    Zittoun R, Bernadou A, Bilski-Pasquier G, Bousser J (1972) Les leucémies myélomonocytaires subaigues. Etude de 27 cas et revue de la littérature. Sem Hop Paris 48: 1943–1956PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg New York 1981

Authors and Affiliations

  • R. Zittoun

There are no affiliations available

Personalised recommendations